Navigation Links
New Report 'Looking at Chiral Technologies' Analyzes the Global,Market Growth Forecasts Driven By Two Very Important Components as,Single Isomer Drugs and Single Enantiomer Pharmaceuticals

DUBLIN, Ireland--(BUSINESS WIRE)--Jun 21, 2007 - Research and Markets (http://www.researchandmarkets.com/reports/c60415) has announced the addition of Looking at Chiral Technologies to their offering.

The advancements in molecular research and continued untiring efforts of the research industry to develop better more precisely applicable Pharmaceuticals as well as agro compounds would have not been possible without the advent of Chiral technologies and their applications.

The usage of chiral molecules is at the very centre of this technological revolution when coupled with the application of chiral technologies as: Chiral Pool, Resolution, Biocatalysts, or asymmetric analysis creates the required compounds. The majority of development activity is routed through fine chemical companies which are additionally trying to upgrade their capabilities in order to provide to the entire portfolio of pharmaceutical drugs for application in the consumer arena.

Such ramping up of operations by companies in order to develop and upgrade basic molecules for wide ranging applications is also bringing the focus of chiral technologies into the development of clinical cures.

This report - Looking at Chiral Technologies - introduces the concept of Chiral Technologies supplementing it with its variants and explaining the actions undertaken by the industry towards developing such compounds jointly and deriving common benefits of clinical nature. The report also analyzes the global market growth forecasts driven by two very important components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals which are synthesized in bulk nature which are contributing to deriving drug streams worldwide.

The report explains the sales of Single Enantiomer pharma on a YOY basis, which is being controlled by certain regulatory constraints. The report also presents an insight on the synergies developed by the industr y majors by building long term partnerships as well as sustaining healthy competition which will lead to the development of the industry as a whole.

The market for Chiral Technologies has been demarcated by end user applications in this report further to which the report provides a future perspective on the industry outlook for Chiral Technologies.

Content Outline:

A. Executive Summary

B. Understanding the Chiral Concept

C. Industry Profile

D. Different Chiral Models for Flexible Markets

E. Intellectual Property Issues

F. Bringing the Molecule to a Commercial Scale - Issues & Challenges

G. How the Pharma Industry is Driving Chiral Technologies

H. Market Demarcations by Chiral Applications

I. Chiral Technology Industry - Future Perspective

J. Major Market Players

K. Appendix

L. Glossary of Terms

Companies Mentioned:

- Altus Biologics Inc

- Ascot Fine Chemicals

- Avecia

- Bachem

- Callery Chemical Company

- Cambrex Corporation

- Catalytica Inc

- Chemi SpA

- ChiRex

- ChromTech International

- Daicel Chemical Industries Ltd

- Daiso Company Ltd

- Degussa-Huls

- DSM

- Great Lakes Fine Chemicals

- IMI (TAMI)

- Johnson Matthey plc

- Kaneka Corporation

- Lonza Ltd

- Novasep

- Oxford Asymmetry International

- Pfanstiehl Laboratories

- PPG-Sipsy

- Sepracor Inc

- Solvias

- Synetix

- Synthon Chiragenics Corporation

For more information visit http://www.researchandmarkets.com/reports/c60415

Contact

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980


'"/>




Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... ... 2020 , ... Breast and ovarian cancers are common diseases that affect many ... cancers (about 7,500 women per year) and 10% of ovarian cancers (about 2,000 women ... genes are detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, ...
(Date:8/31/2020)... ... , ... Continuing on its rapid national expansion - ... provider - is proud to announce it has opened doors in Phoenix, Arizona. ... throughout the area. , Germinator provides a 100% safe and non-toxic sanitizing and ...
(Date:8/28/2020)... ... 2020 , ... Dr. Raheleh Sarbaziha has been reimagining the ... Armed with her qualifications from Ross University School of Medicine and the University ... body with the nation and world. With a fellowship in Integrative Medicine Dr. ...
Breaking Medicine Technology:
(Date:9/3/2020)... , ... September 03, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Louisville, KY. The ... features and amenities. , According to the Alzheimer’s Association , 5.6 ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first organization in ... Disorder (PFD), is pleased to announce that the U.S. Centers for Disease Control and ... in the next edition of the U.S. International Classification of Diseases (ICD ) ...
(Date:8/31/2020)... CHESTER, N.J. (PRWEB) , ... August 31, 2020 , ... Just found out your dear ... cancer.” It’s heartbreaking when your friend or family member shares their diagnosis. Once the shock ... if I say the wrong thing? What are the best ways to help? Words are ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... services to dental groups in the United States, today announced the grand opening ... Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, and ...
(Date:8/31/2020)... HAVEN, Conn. (PRWEB) , ... August 31, 2020 ... ... medical device intended to improve outcomes for patients with advanced heart failure, today ... Research (SBIR) grant in the amount of $555,358 from the National Heart, Lung, ...
Breaking Medicine News(10 mins):